Provided is an antimalarial that effectively acts against malaria caused by Plasmodium infection, particularly chloroquine-resistant and/or artemisinin-resistant Plasmodium infection. Further provided is an antimalarial with which the efficacy of an active ingredient is effectively sustainable. The antimalarial contains a peroxide derivative represented by general formula (I) or pharmaceutically acceptable salt thereof as the active ingredient. When used in the form of a percutaneous absorption-type pharmaceutical preparation, the antimalarial acts effectively against malaria because the active ingredient gradually moves into the blood and the effective plasma concentration is sustainable for 12 hours or longer. (In the formula, C is an optionally substituted alicyclic hydrocarbon group and n is an integer of 0 to 6.)
申请公布号
WO2016063848(A1)
申请公布日期
2016.04.28
申请号
WO2015JP79511
申请日期
2015.10.20
申请人
NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY
发明人
KIM, HYE-SOOK;WATAYA, YUSUKE;SATO, AKIRA;DOI, HIROYUKI